ReviewTherapeutic advances in neurological disorders2025

The therapeutic effects and mechanisms of glucagon-like peptide-1 receptor agonists in neurocognitive disorders.

Junchen Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.